(Q35477688)

8 August 2017

1 reference

title

Hemostatic alterations in cancer patients (English)

1 reference

8 August 2017

F. R. Rickles

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1423816

25 September 2022

M. Levine

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1423816

25 September 2022

R. L. Edwards

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1423816

25 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1423816

25 September 2022

publication date

1 November 1992

1 reference

Cancer and Metastasis Reviews

8 August 2017

1 reference

8 August 2017

11

1 reference

8 August 2017

3-4

1 reference

8 August 2017

237-248

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01307180

8 August 2017

0 references

cites work

Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency

1 reference

12 December 2020

Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemia

1 reference

12 December 2020

Perioperative external pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: report of a randomized controlled trial

1 reference

12 December 2020

Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia

1 reference

12 December 2020

Elevated fibrinopeptide A levels in patients with clinically localised breast carcinoma

1 reference

12 December 2020

Antimetastatic agents. I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatment

1 reference

12 December 2020

von Willebrand factor in head and neck cancer

1 reference

12 December 2020

Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients

1 reference

12 December 2020

Venous thromboembolism prophylaxis in gynecologic oncology: A prospective, controlled trial of low-dose heparin

1 reference

12 December 2020

Significance of plasma fibrinopeptide A (fpA) in patients with malignancy

1 reference

12 December 2020

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

1 reference

12 December 2020

Prevention of postoperative deep-vein thrombosis by low-dose heparin in urological surgery. A double-blind, randomised study

1 reference

12 December 2020

Hemostatic Abnormalities in Malignancy, a Prospective Study of One Hundred Eight Patients: Part I. Coagulation Studies

1 reference

12 December 2020

Reassessing the hemostatic disorder associated with acute promyelocytic leukemia

1 reference

12 December 2020

Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study

1 reference

12 December 2020

Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity.

1 reference

12 December 2020

Prevention of venous thrombosis by intermittent sequential calf compression in patients with intracranial disease

1 reference

12 December 2020

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients

1 reference

12 December 2020

The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination

1 reference

12 December 2020

A new procoagulant in acute leukemia

1 reference

12 December 2020

Measurements of antithrombin III in solid tumor patients with and without hepatic metastases

1 reference

12 December 2020

Fibrinopeptide A in acute leukemia: relationship of activation of blood coagulation to disease activity

1 reference

12 December 2020

Activation of blood coagulation in cancer: Trousseau's syndrome revisited.

1 reference

12 December 2020

Fibrinogen kinetics in patients with neoplastic disease

1 reference

12 December 2020

Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications

1 reference

12 December 2020

Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells: reversal of the bleeding disorder by cell differentiation.

1 reference

12 December 2020

Venous thrombosis during multimodal treatment of primary breast carcinoma

1 reference

12 December 2020

Tissue factor activity in leukemia cells. Special reference to disseminated intravascular coagulation

1 reference

12 December 2020

Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarction

1 reference

12 December 2020

Animal tumor procoagulants: registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society of Thrombosis and Haemostasis

1 reference

12 December 2020

Prevention of deep vein thrombosis in neurosurgical patients: a controlled, randomized trial of external pneumatic compression boots

1 reference

12 December 2020

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.

1 reference

12 December 2020

Prevention of deep vein thrombosis in urological patients: a controlled, randomized trial of low-dose heparin and external pneumatic compression boots

1 reference

12 December 2020

Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease

1 reference

12 December 2020

Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis

1 reference

12 December 2020

Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy

1 reference

12 December 2020

Tissue factor released from leukemic cells

1 reference

12 December 2020

Thrombin generation in acute promyelocytic leukemia

1 reference

12 December 2020

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

12 December 2020

A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis

1 reference

12 December 2020

Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy

1 reference

12 December 2020

Fibrinogen degradation products in serum from patients with cancer

1 reference

12 December 2020

Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias

1 reference

12 December 2020

The coagulopathy of childhood leukemia. Thrombin activation or primary fibrinolysis?

1 reference

12 December 2020

Protein C and S levels in acute leukemia

1 reference

12 December 2020

Fibrinogen survival and fibrinolysis in acute leukemia

1 reference

12 December 2020

The role of leukocytes in the activation of blood coagulation

1 reference

12 December 2020

Heparin abolishes the chemotherapy-induced increase in plasma fibrinopeptide A levels.

1 reference

12 December 2020

Disseminated intravascular coagulation and related syndromes: a clinical review

1 reference

12 December 2020

Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders

1 reference

12 December 2020

An evaluation of suloctidil in the prevention of deep vein thrombosis in neurosurgical patients.

1 reference

12 December 2020

Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia

1 reference

12 December 2020

Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients

1 reference

12 December 2020

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial

1 reference

12 December 2020

Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf

1 reference

12 December 2020

Abnormalities of blood coagulation tests in patients with cancer

1 reference

12 December 2020

Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth

1 reference

12 December 2020

Antithrombin III profiles in malignancy, relationship primary tumors and metastatic sites

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01307180

1 reference

8 August 2017

1 reference